Survival analysis

Relevant publications

1. O. Alagoz, A. Winge-Main, S. Srinivasan, M. Dyer, R. Wolf, S. H. Thybo, J. R. May, A. Moshyk, and M. Kurt (2023). "MSR12 Analysis of Long-Term Survivorship (LTS) Rates for Stage 2B/2C Melanoma Using Published Real-World Data (RWD) and Data From Randomized Controlled Trials (RCTS)." Value in Health 26(12): S395. Poster presentation at ISPOR-Europe Annual Conference, November 12-15, 2023,  Copenhagen, Denmark.

2. O. Alagoz, J. Ajani, S. Srinivasan, I. Kim, P. Singh, and M. Kurt (2023). "An indirect assessment of individual-level association between disease-free survival (DFS) and overall survival (OS) for resectable esophageal or gastroesophageal junction cancer (EC/GEJC): A pooled analysis of randomized controlled trials (RCTs) by an illness-death model."  Journal of Clinical Oncology, 41(4):S369. Poster presentation at ASCO Gastrointestinal Cancers Symposium, January 19-21, 2023, San Francisco, California.   

3. O. Alagoz,  J. Ajani, S. Srinivasan, I. Kim, P. Singh, H. Xiao, and M. Kurt (2022). "Estimating endpoint correlation between surrogate measures and overall survival using reconstructed survival data: Case studies from adjuvant and metastatic gastric cancer trials." Annals of Oncology, 33: S267. Poster presentation at ESMO World Congress on Gastrointestinal Cancer,  June 29-July 2, 2022, Barcelona, Spain.

4. O. Alagoz, H. Xiao, P. Singh, J. Gricar, M. Dixon, I. Kim, and M. Kurt (2022). "P46 Effective Use of Reconstructed Survival and Comparative Effectiveness Data: A Case Study from Estimating Unreported Subgroup Survival in Advanced Stage Gastrointestinal Cancers." Value in Health 25(1): S10. Oral presentation at ISPOR-Europe Annual Conference, November 30-December 3, 2021, virtual.

5. O. Alagoz, S. Srinivasan, H. Xiao, P. Singh, J. Gricar, M. Dixon, I. Kim, and M. Kurt (2022). "MSR104 Assessing the Impact of Integrating Extrapolated Long-Term Outcomes Into Elicitation of Unreported Subgroup-Specific Survival in Randomized Controlled Trials (RCTS): Insights From Advanced Stage Gastrointestinal Cancers." Value in Health 25(12): S370.  Poster presentation at ISPOR-Europe Annual Conference, November 6-9, 2022, Vienna, Austria, and virtual. 

6. O. Alagoz, H. Xiao, P. Singh, J. Gricar, M. Dixon, and M. Kurt (2021). "CN2 Eliciting Unreported Subgroup-Specific Survival from Aggregate Randomized Controlled Trial Data." Value in Health 24 (2021): S3. Oral presentation at ISPOR Annual Conference, May 17-20, 2021, virtual.